Please note that a publication can be assigned to several endpoints, i.e. the sum of publications from the individual thematic points and subpoints can be greater than the total sum of actual publications.
| Authors | Year | Exposed system | Parameters | Magnetic flux density/field strength |
|---|---|---|---|---|
| Lange S et al. | 2024 | intact cell/cell culture, PC3 cells (human prostate cancer cell line) and PNT2 cells (prostate epithelial cell line) | geomagnetic field, shielding/field deprivation | - |
| Di Costanzo N et al. | 2024 | bacterium, microorganisms in sludge | static magnetic field | - |
| Eydelkhani M et al. | 2024 | bacterium, cyanobacterium (<i>Alborzia kermanshahica</i>) | static magnetic field | - |
| Eldashev IS et al. | 2010 | intact cell/cell culture, satellite muscle cells (newborn rat) | static magnetic field, geomagnetic field, shielding/field deprivation | 0.3–160 µT |
| Barnaba SA et al. | 2012 | intact cell/cell culture | static magnetic field, low frequency, signals/pulses, 50/60 Hz, DC | 0.9 µT–0.4 mT |
| Ledda M et al. | 2013 | intact cell/cell culture, NT2 (human pluripotent embryonal carcinoma cells) | magnetic field, static magnetic field, low frequency | 2.5–10 µT |
| Teichmann EM et al. | 2000 | bacterium, <i>Salmonella typhimurium</i> (TA98, TA100, TA102, TA1535, TA1537, wild type RTA) | RF, static magnetic field, MRI, co-exposure | 5.8 µT–7.2 T |
| Fox SJ et al. | 2011 | intact cell/cell culture, THP-1 cells (human monocytic leukemia cell line) | magnetic field, static magnetic field, low frequency | 11.9–45.1 µT |
| De Carlo F et al. | 2012 | intact cell/cell culture, C2C12 cells (undifferentiated mouse myoblasts) | magnetic field, static magnetic field, low frequency, co-exposure, therapeutic/medical device | 18 µT |
| Gavoci E et al. | 2013 | intact cell/cell culture, human neuroblastoma cell line (BE(2)C) | magnetic field, static magnetic field | 20.4–101.2 µT |
This website uses cookies to provide you the best browsing experience. By continuing to use this website you accept our use of cookies.
